Endometrial cancer: open trials in Chile

• NCT07022483

  A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting

  Trial Treatment · Phase 3 · Daiichi Sankyo

  Biocenter, Concepción · Centro de Investigaciones Clinicas de la Universidad Catolica, Santiago · Centro de Estudios Clínicos SAGA, Santiago

  Registry updated 2026-10-27

• NCT06330064

  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Trial Treatment · Phase 1/2 · Daiichi Sankyo

  Biocenter, Concepción · Ic La Serena Research, La Serena · Clinica Redsalud Vitacura, Santiago · Centro Del Cancer UC, Santiago · James Lind Centro De Investigacion Del Cancer, Temuco

  Registry updated 2026-10-26

• NCT06952504

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Fundación Arturo López Pérez (Site 0702), Santiago · Centro de Estudios Clínicos SAGA (Site 0708), Santiago · Bradfordhill (Site 0703), Santiago · Pontificia Universidad Catolica de Chile (Site 0705), Santiago · ONCOCENTRO APYS (Site 0704), Viña del Mar

  Registry updated 2026-10-13

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error